Medindia

X

West Pharmaceutical Services to Present at the CJS Securities Investor Conference

Tuesday, August 14, 2007 General News J E 4
Advertisement
LIONVILLE, Pa., Aug. 13 West PharmaceuticalServices, Inc. (NYSE: WST) today announced that William Federici, VicePresident and Chief Financial Officer, and Michael Anderson, Vice Presidentand Treasurer, of West Pharmaceutical Services, Inc., will be presenting atthe CJS Securities 7th Annual Summer "New Ideas" Small-Cap Investor Conferencein White Plains, NY, on August 14, 2007. A copy of the Company's presentationfrom the conference will be available through the Investor link of theCompany's website, www.westpharma.com.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is the world's premier manufacturer ofcomponents and systems for injectable drug delivery, including stoppers andseals for vials, and closures and disposable components used in syringe, IVand blood collection systems. The Company also provides products withapplication to the personal care, food and beverage markets. West's customersinclude the world's leading pharmaceutical, biotechnology, generic drug andmedical device producers. Headquartered in Lionville, Pennsylvania, WestPharmaceutical Services supports its partners and customers from 50 locationsthroughout North America, South America, Europe, Mexico, Japan, Asia andAustralia. For more information, visit West at http://www.westpharma.com.Contacts: West Pharmaceutical Services, Inc. Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Financial Dynamics Julie Huang / Theresa Kelleher (212) 850-5600 wst@fd-us.com

SOURCE West Pharmaceutical Services, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pregis Announces Second Quarter 2007 Financial Res...
S
Ardea Biosciences, Inc. Reports Second Quarter 200...